Association study of APC polymorphisms with colorectal cancer in Han Chinese

Clinical Biochemistry

Volumn 45, Issue 18, 2012, Pages 1669-1672

  Huang, Xiaoye ^a,b,d   Wang, Yang ^a,d   Yu, Tao ^a,d   Liu, Baocheng ^a,d   Li, Xin ^a,d   Li, Weidong ^a,d   Chen, Shiqing ^a,d   Zhao, Qingzhu ^a,d   Li, Xingwang ^a,d   Yang, Fengping ^a,d   Wang, Quan ^f   Wang, Jinfen ^g   Xiao, Yanzeng ^g   Xu, Yifeng ^e   Feng, Guoyin ^e   Peng, Zhihai ^f   He, Lin ^a,b,c,d   He, Guang ^a,b,d  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Shanghai GenomePilot Institutes for Genomics and Human Health   (China)

^c FUDAN UNIVERSITY   (China)

^d Chinese Academy of Sciences   (China)

^e SHANGHAI MENTAL HEALTH CENTER   (China)

^f SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

^g SHANXI CANCER HOSPITAL   (China)

Author keywords

APC gene; Association; Chinese Han population; Colorectal cancer

Indexed keywords

ADULT; AGED; APC GENE; ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; ETHNIC GROUP; FAMILIAL COLON POLYPOSIS; FEMALE; GENE; GENE MUTATION; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADENOMATOUS POLYPOSIS COLI PROTEIN; ADULT; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; COLORECTAL NEOPLASMS; ETHNIC GROUPS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84870704398     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2012.07.001     Document Type: Article

References (34)

1. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108.
2. Hyodo I., Suzuki H., Takahashi K., Saito Y., Tanaka S., Chiu H.M., et al. Present status and perspectives of colorectal cancer in asia: colorectal cancer working group report in 30th asia-pacific cancer conference. Jpn J Clin Oncol 2010, 40:i38-i43.
3. Rustgi A.K. The genetics of hereditary colon cancer. Genes Dev 2007, 21:2525-2538.
4. Groden J., Thliveris A., Samowitz W., Carlson M., Gelbert L., Albertsen H., et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991, 66:599-600.
5. Kinzler K.W., Nilbert M.C., Su L.K., Vogelstein B., Bryan T.M., Levy D.B., et al. Identification of fap locus genes from chromosome 5q21. Science 1991, 253:661-665.
6. Weitz J., Koch M., Debus J., Höhler T., Galle P.R., Büchler M.W. Colorectal cancer. Lancet 2005, 365:153-165.
7. Debinski H.S., Love S., Spigelman A.D., Phillips R.K.S. Colorectal polyp counts and cancer risk in familial adenomatous polyposis. Gastroenterology 1996, 110:1028-1030.
8. Narayan S., Roy D. Role of apc and DNA mismatch repair genes in the development of colorectal cancers. Mol Cancer 2003, 2.
9. Goyette M.C., Cho K., Fasching C.L., Levy D.B., Kinzler K.W., Paraskeva C., et al. Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer. Mol Cell Biol 1992, 12:1387-1395.
10. Groden J., Joslyn G., Samowitz W., Jones D., Bhattacharyya N., Spirio L., et al. Response of colon cancer cell lines to the introduction of apc, a colon-specific tumor suppressor gene. Cancer Res 1995, 55:1531-1539.
11. Rubinfeld B., Souza B., Albert I., Muller O., Chamberlain S.H., Masiarz F.R., et al. Association of the apc gene product with beta-catenin. Science 1993, 262:1731-1734.
12. Heinen C.D. Genotype to phenotype: analyzing the effects of inherited mutations in colorectal cancer families. Mutat Res Fundam Mol Mech Mutagen 2010, 693:32-45.
13. Munemitsu S., Albert I., Souza B., Rubinfeld B., Polakis P. Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (apc) tumor-suppressor protein. Proc Natl Acad Sci U S A 1995, 92:3046-3050.
14. Sierra J., Yoshida T., Joazeiro C.A., Jones K.A. The apc tumor suppressor counteracts β-catenin activation and h3k4 methylation at wnt target genes. Genes Dev 2006, 20:586-600.
15. Morrison E.E., Wardleworth B.N., Askham J.M., Markham A.F., Meredith D.M. Eb1, a protein which interacts with the apc tumour suppressor, is associated with the microtubule cytoskeleton throughout the cell cycle. Oncogene 1998, 17:3471-3477.
16. Wong H.L., Peters U., Hayes R.B., Huang W.Y., Schatzkin A., Bresalier R.S., et al. Polymorphisms in the adenomatous polyposis coli (apc) gene and advanced colorectal adenoma risk. Eur J Cancer 2010, 46:2457-2466.
17. Chen S.P., Tsai S.T., Jao S.W., Huang Y.L., Chen Y.L., Wu C.C., et al. Single nucleotide polymorphisms of the apc gene and colorectal cancer risk: a case-control study in taiwan. BMC Cancer 2006, 6.
18. Shi Y.Y., He L. Shesis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 2005, 15:97-98.
19. Sham P.C., Curtis D. Monte carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet 1995, 59:97-105.
20. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of ld and haplotype maps. Bioinformatics 2005, 21:263-265.
21. Goel A., Boland C.R. Recent insights into the pathogenesis of colorectal cancer. Curr Opin Gastroenterol 2010, 26:47-52.
22. Tenesa A., Dunlop M.G. New insights into the aetiology of colorectal cancer from genome-wide association studies. Nat Rev Genet 2009, 10:353-358.
23. Pritchard J.K., Cox N.J. The allelic architecture of human disease genes: common disease-common variant. or not?. Hum Mol Genet 2002, 11:2417-2423.
24. Crabtree M., Sieber O.M., Lipton L., Hodgson S.V., Lamlum H., Thomas H.J., et al. Refining the relation between 'first hits' and 'second hits' at the apc locus: the 'loose fit' model and evidence for differences in somatic mutation spectra among patients. Oncogene 2003, 22:4257-4265.
25. Nagase H., Nakamura Y. Mutations of the apc (adenomatous polyposis coli) gene. Hum Mutat 1993, 2:425-434.
26. Menendez M., Gonzalez S., Blanco I., Guino E., Peris M., Peinado M.A., et al. Colorectal cancer risk and the apc d1822v variant. Int J Cancer 2004, 112:161-163.
27. Tranah G.J., Giovannucci E., Ma J., Fuchs C., Hunter D.J. Apc asp1822val and gly2502ser polymorphisms and risk of colorectal cancer and adenoma. Cancer Epidemiol Biomarkers Prev 2005, 14:863-870.
28. Olschwang S., Vernerey D., Cottet V., Pariente A., Nalet B., Lafon J., et al. Analysis of candidate genes in occurrence and growth of colorectal adenomas. J Oncol 2009, 10.1155/2009/306786.
29. Picelli S., Zajac P., Zhou X.L., Edler D., Lenander C., Dalén J., et al. Common variants in human crc genes as low-risk alleles. Eur J Cancer 2010, 46:1041-1048.
30. Theodoratou E., Campbell H., Tenesa A., McNeill G., Cetnarskyj R., Barnetson R.A., et al. Modification of the associations between lifestyle, dietary factors and colorectal cancer risk by apc variants. Carcinogenesis 2008, 29:1774-1780.
31. Mathew A., Peters U., Chatterjee N., Kulldorff M., Sinha R. Fat, fiber, fruits, vegetables, and risk of colorectal adenomas. Int J Cancer 2004, 108:287-292.
32. Robertson D.J., Sandler R.S., Haile R., Tosteson T.D., Greenberg E.R., Grau M., et al. Fat, fiber, meat and the risk of colorectal adenomas. Am J Gastroenterol 2005, 100:2789-2795.
33. Terry M.B., Neugut A.I., Bostick R.M., Sandler R.S., Haile R.W., Jacobson J.S., et al. Risk factors for advanced colorectal adenomas: a pooled analysis. Cancer Epidemiol Biomarkers Prev 2002, 11:622-629.
34. Purdue M.P., Mink P.J., Hartge P., Huang W.Y., Buys S., Hayes R.B. Hormone replacement therapy, reproductive history, and colorectal adenomas: data from the prostate, lung, colorectal and ovarian (plco) cancer screening trial (united states). Cancer Causes Control 2005, 16:965-973.